3billion, Inc. (KOSDAQ: A394800)
Health Care · Biotechnology · KR
₩5,900.00
-2.32% today · -22.3% 1Y
3billion, Inc. (KOSDAQ: A394800) operates in the Biotechnology industry within the Health Care sector. The company is valued at $139.66M.
Over the last twelve months the share price has lost 22.3%, trading between 4.02K and 20.10K.
Tweenvest scores 3billion, Inc. across four factors: quality 43/100, value 65/100, growth 100/100. Its strongest factor is growth.
A394800 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $139.66M
- Revenue (TTM)
- $8.11M
- P/E
- —
- EPS
- -171.00
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩20,100.00
- 52-week low
- ₩4,020.00
- Avg volume (3M)
- —
- Shares outstanding
- 31.82M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Atrium Therapeutics, Inc.NasdaqGS: RNA | $143.69M | $7.62 | -9.29% |
| UnicoCell Biomed Co., Ltd.TWSE: 6794 | $142.50M | NT$71.60 | -9.25% |
| Cue Biopharma, Inc.NasdaqCM: CUE | $142.16M | $18.65 | -4.70% |
| Cloudbreak Pharma Inc.SEHK: 2592 | $140.32M | HK$— | — |
| NeoImmuneTech, Inc.KOSDAQ: A950220 | $139.14M | ₩1,892.00 | -4.69% |
| Outlook Therapeutics, Inc.NasdaqCM: OTLK | $137.26M | $0.51 | -9.51% |
| Anavex Life Sciences Corp.NasdaqGS: AVXL | $137.19M | $1.52 | +2.36% |
| ALX Oncology Holdings Inc.NasdaqGS: ALXO | $135.46M | $0.90 | -8.18% |
Figures last refreshed Oct 11, 2026.